Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) will be releasing its earnings data before the market opens on Tuesday, June 27th. Analysts expect Walgreens Boots Alliance to post earnings of $1.10 per share for the quarter. Walgreens Boots Alliance has set its FY23 guidance at $4.45-4.65 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last released its quarterly earnings results on Tuesday, March 28th. The pharmacy operator reported $1.16 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.06. The company had revenue of $34.86 billion for the quarter, compared to the consensus estimate of $33.56 billion. Walgreens Boots Alliance had a negative net margin of 2.36% and a positive return on equity of 12.42%. Walgreens Boots Alliance’s revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.59 EPS. On average, analysts expect Walgreens Boots Alliance to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Walgreens Boots Alliance Trading Up 2.0 %
Walgreens Boots Alliance stock opened at $32.67 on Tuesday. Walgreens Boots Alliance has a 12-month low of $29.48 and a 12-month high of $42.74. The stock has a market capitalization of $28.19 billion, a PE ratio of -8.95, a price-to-earnings-growth ratio of 1.26 and a beta of 0.72. The firm has a 50 day simple moving average of $32.60 and a 200-day simple moving average of $35.12. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.63 and a quick ratio of 0.32.
Walgreens Boots Alliance Announces Dividend
Insider Activity at Walgreens Boots Alliance
In other Walgreens Boots Alliance news, CEO Rosalind G. Brewer acquired 10,000 shares of the company’s stock in a transaction dated Wednesday, March 29th. The shares were acquired at an average cost of $33.95 per share, for a total transaction of $339,500.00. Following the completion of the purchase, the chief executive officer now owns 369,945 shares of the company’s stock, valued at approximately $12,559,632.75. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 17.40% of the stock is owned by company insiders.
Institutional Trading of Walgreens Boots Alliance
A number of hedge funds have recently modified their holdings of WBA. Milestone Investment Advisors LLC bought a new position in Walgreens Boots Alliance during the 1st quarter valued at about $31,000. Penserra Capital Management LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $34,000. Financial Freedom LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $46,000. Compass Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $47,000. Finally, Salem Investment Counselors Inc. increased its holdings in Walgreens Boots Alliance by 1,120.5% during the 2nd quarter. Salem Investment Counselors Inc. now owns 1,367 shares of the pharmacy operator’s stock valued at $52,000 after purchasing an additional 1,255 shares in the last quarter. Institutional investors own 57.89% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on WBA shares. UBS Group decreased their price target on shares of Walgreens Boots Alliance from $39.00 to $37.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 29th. StockNews.com initiated coverage on Walgreens Boots Alliance in a research report on Thursday, May 18th. They issued a “hold” rating for the company. Barclays reduced their price objective on shares of Walgreens Boots Alliance from $45.00 to $43.00 in a research note on Sunday, March 26th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Walgreens Boots Alliance from $47.00 to $46.00 and set a “buy” rating on the stock in a research report on Thursday, March 30th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Walgreens Boots Alliance from $40.00 to $43.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 29th. One analyst has rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $42.00.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.
Featured Stories
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- Trading Stocks: RSI and Why it’s Useful
- Why Mosaic’s Price Targets May Be Understated
- Amazon And The AI War: iRobot Acquisition In Focus
- What Does Logitech CEO’s Abrupt Departure Mean?
- Ulta Beauty Stock Value is More Than Skin Deep
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.
